Azaya Therapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $170M

Azaya Therapeutics General Information

Description

Developer of a nanotechnology platform designed to support the formulation, manufacturing and use of many different active ingredients for drugs. The company's nanotechnology platform addresses the toxicity problems associated with delivery of cancer treatments by building liposome encapsulating therapeutic compounds in the lipid bi-layer, enabling doctors to treat cancer with advanced therapeutic drugs.

Contact Information

Website
www.azayatherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 12672 Silicon Drive
  • Suite 150
  • San Antonio, TX 78249
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Acquirer
Plus Therapeutics
Vertical(s)
Nanotechnology, TMT, Life Sciences, Oncology
Corporate Office
  • 12672 Silicon Drive
  • Suite 150
  • San Antonio, TX 78249
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azaya Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-Feb-2017 $170M Completed Generating Revenue
2. Later Stage VC 31-May-2011 Completed Generating Revenue
1. Later Stage VC 29-Sep-2009 $1.04M $1.04M Completed Generating Revenue
To view Azaya Therapeutics’s complete valuation and funding history, request access »

Azaya Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nanotechnology platform designed to support the formulation, manufacturing and use of many different acti
Biotechnology
San Antonio, TX
11 As of 2016

Middleton, WI
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Azaya Therapeutics Competitors (79)

One of Azaya Therapeutics’s 79 competitors is Centrose, a Venture Capital-Backed company based in Middleton, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrose Venture Capital-Backed Middleton, WI
CytImmune Sciences Private Equity-Backed Rockville, MD
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
You’re viewing 5 of 79 competitors. Get the full list »

Azaya Therapeutics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Azaya Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003291302-A1 Method for treatment of premature ejaculation in humans Inactive 06-Nov-2002
CA-2505520-A1 Protein-stabilized liposomal formulations of pharmaceutical agents Active 06-Nov-2002
AU-2003291302-A8 Method for treatment of premature ejaculation in humans Inactive 06-Nov-2002
CA-2505520-C Protein-stabilized liposomal formulations of pharmaceutical agents Inactive 06-Nov-2002
US-20040082521-A1 Uses variety of liposomal-digitalis glycoside compositions; also provides protein-stabilized nanoparticle formulations containing liposomal-digitalis glycosides such as oleandrin, digitoxin, and digoxin with reduced toxicity Inactive 29-Mar-2002 A61K31/7048
To view Azaya Therapeutics’s complete patent history, request access »

Azaya Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azaya Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Texas Emerging Technology Fund Venture Capital Minority
To view Azaya Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Azaya Therapeutics FAQs

  • When was Azaya Therapeutics founded?

    Azaya Therapeutics was founded in 2003.

  • Where is Azaya Therapeutics headquartered?

    Azaya Therapeutics is headquartered in San Antonio, TX.

  • What is the size of Azaya Therapeutics?

    Azaya Therapeutics has 11 total employees.

  • What industry is Azaya Therapeutics in?

    Azaya Therapeutics’s primary industry is Biotechnology.

  • Is Azaya Therapeutics a private or public company?

    Azaya Therapeutics is a Private company.

  • What is the current valuation of Azaya Therapeutics?

    The current valuation of Azaya Therapeutics is .

  • What is Azaya Therapeutics’s current revenue?

    The current revenue for Azaya Therapeutics is .

  • How much funding has Azaya Therapeutics raised over time?

    Azaya Therapeutics has raised $4.54M.

  • Who are Azaya Therapeutics’s investors?

    Texas Emerging Technology Fund has invested in Azaya Therapeutics.

  • Who are Azaya Therapeutics’s competitors?

    Centrose, CytImmune Sciences, Cristal Therapeutics, Noveome Biotherapeutics, and CRISPR Therapeutics are some of the 79 competitors of Azaya Therapeutics.

  • When was Azaya Therapeutics acquired?

    Azaya Therapeutics was acquired on 15-Feb-2017.

  • Who acquired Azaya Therapeutics?

    Azaya Therapeutics was acquired by Plus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »